Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis

Open access
Amor-García, Miguel Ángel, Collado-Borrell, Roberto, Escudero-Vilaplana, Vicente, Melgarejo-Ortuño, Alejandra, Herranz-Alonso, Ana, Arranz Arija, José Ángel, Sanjurjo-Sáez, María · 2020 · JMIR mHealth and uHealth

Published version of a preprint

Abstract

Background: The large number of available cancer apps and their impact on the population necessitates a transparent, objective, and comprehensive evaluation by app experts, health care professionals, and users. To date, there have been no analyses or classifications of apps for patients with genitourinary cancers, which are among the most prevalent types of cancer. Objective: The objective of our study was to analyze the quality of apps for patients diagnosed with genitourinary cancers using the Mobile Application Rating Scale (MARS) and identify high-quality apps. Methods: We performed an observational cross-sectional descriptive study of all smartphone apps for patients diagnosed with genitourinary cancers available on iOS and Android platforms. In July 2019, we searched for all available apps for patients with genitourinary cancers (bladder, prostate, cervical, uterine, endometrial, kidney, testicular, and vulvar) or their caregivers. Apps were downloaded and evaluated, and the general characteristics were entered into a database. The evaluation was performed by 2 independent researchers using the MARS questionnaire, which rates 23 evaluation criteria clustered in 5 domains (Engagement, Functionality, Esthetics, Information, and Subjective Quality) on a scale from 1 to 5. Results: In total, 46 apps were analyzed. Of these, 31 (67%) were available on Android, 6 (13%) on iOS, and 9 (20%) on both platforms. The apps were free in 89% of cases (41/46), and 61% (28/46) had been updated in the previous year. The apps were intended for prostate cancer in 30% of cases (14/46) and cervical cancer in 17% (8/46). The apps were mainly informative (63%, 29/46), preventive (24%, 11/46), and diagnostic (13%, 6/46). Only 7/46 apps (15%) were developed by health care organizations. The mean MARS score for the overall quality of the 46 apps was 2.98 (SD 0.77), with a maximum of 4.63 and a minimum of 1.95. Functionality scores were quite similar for most of the apps, with the greatest differences in Engagement and Esthetics, which showed acceptable scores in one-third of the apps. The 5 apps with the highest MARS score were the following: “Bladder cancer manager,” “Kidney cancer manager,” “My prostate cancer manager,” “Target Ovarian Cancer Symptoms Diary,” and “My Cancer Coach.” We observed statistically significant differences in the MARS score between the operating systems and the developer types (P<.001 and P=.01, respectively), but not for cost (P=.62). Conclusions: MARS is a helpful methodology to decide which apps can be prescribed to patients and to identify which features should be addressed to improve these tools. Most of the apps designed for patients with genitourinary cancers only try to provide data about the disease, without coherent interactivity. The participation of health professionals in the development of these apps is low; nevertheless, we observed that both the participation of health professionals and regular updates were correlated with quality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2196/17609

Cites

Statistics

Figures

Figure 1 Study flowchart. MARS: Mobile Application Rating Scale.
Figure 1 Study flowchart. MARS: Mobile Application Rating Scale.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 26 · Cited by 49

Research works printed but not linked: 2

  1. Jiang, Y, 2017, Stud Health Technol Inform, 245, 131
  2. Cantudo-Cuenca, M, 2014, Farm Hosp, 38, 112

Metadata

Authors
Amor-García, M. Á., Collado-Borrell, R., Escudero-Vilaplana, V., Melgarejo-Ortuño, A., Herranz-Alonso, A., Arranz Arija, J. Á., & Sanjurjo-Sáez, M.
Affiliations
Hospital General Universitario Gregorio Marañón (ES)
Venue
JMIR mHealth and uHealth
Published
2020-07-23
Volume
8
Issue
7
Pages
e17609
ISSN
2291-5222 (ISSN-L)
OpenAlex
W3013055273
Cited by
49
References
26
Citations by year
2026: 1 · 2025: 12 · 2024: 9 · 2023: 5 · 2022: 16 · 2021: 5 · 2020: 1
FWCI
7.04
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JMIR mhealth and uhealth (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Health Professions › Health Information Management › Health, Technology, Consumer Behavior
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
genitourinary cancer, Mobile App Rating Scale, app quality assessment, mobile health, prostate cancer, cervical cancer, bladder cancer, uterine cancer, endometrial cancer, kidney cancer, testicular cancer, vulvar cancer, app store search, app functionality, app engagement, app aesthetics, app developers, caregivers, Android and iOS apps
MeSH terms
Cross-Sectional Studies, Delivery of Health Care, Female, Humans, Male, Surveys and Questionnaires, Urogenital Neoplasms, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis. https://app.cochat.ai/papers/10.2196/17609
The paper
Amor-García, M. Á., Collado-Borrell, R., Escudero-Vilaplana, V., Melgarejo-Ortuño, A., Herranz-Alonso, A., Arranz Arija, J. Á., & Sanjurjo-Sáez, M. (2020). Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis. JMIR mHealth and uHealth. https://doi.org/10.2196/17609

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.